Sleep &amp; Mindfulness

Daily Coffee and Tea May Cut Dementia Risk by 18% in 43-Year Study

Moderate caffeine intake from coffee or tea linked to better brain health and slower cognitive decline in massive long-term study.

Press Release

Red Blood Cells Successfully Deliver Healthy Mitochondria to Treat Parkinson's Disease

Scientists used red blood cells to transport healthy mitochondria into diseased brain cells, showing promise for Parkinson's treatment.

Press Release

Mar 28, 2026 0

Psilocybin Therapy Shows Promise for End-of-Life Psychological Distress

Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.

Yale Psilocybin Trial for Post-Concussion Headaches Shows Promise Despite Early End

Small Yale study tested magic mushroom compound for chronic headaches after brain injury, tracking symptoms and inflammation markers.

Psilocybin Shows Promise for Obsessive-Compulsive Disorder in Yale Clinical Trial

Yale researchers tested psilocybin's effects on OCD symptoms in a controlled trial, exploring potential therapeutic benefits.

SSRI Antidepressants May Block Psychedelic Effects by Reducing Brain Receptors

Swiss researchers tested whether paroxetine reduces LSD response by downregulating serotonin receptors in healthy adults.

Psilocybin Shows Promise for Treatment-Resistant Depression in Clinical Trial

Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.

LSD Shows Promise for Treating Anxiety in Life-Threatening Illness Study

Swiss researchers tested LSD-assisted therapy for anxiety disorders in a controlled crossover trial with 46 participants.

Psilocybin Shows Promise for Anorexia Nervosa in Small Clinical Trial

UC San Diego researchers tested psilocybin's safety and potential benefits for eating disorder symptoms in 16 participants with anorexia nervosa.

Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults

Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.

Mar 28, 2026 2

New Alzheimer's Drug BMS-984923 Completes Safety Testing in 51 Participants

Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.